Introduction
============

Strict glycemic control has been recommended for critically ill patients. However, its implementation may face difficulties with increased nursing workload, inadequate glucose control and higher risk of hypoglycemia.

Objective
=========

We report the results of a randomized controlled trial to evaluate the efficacy and safety of three insulin algorithms in medical ICU (MICU) patients.

Methods
=======

MICU patients with at least one blood glucose ≥150 mg/dl and who were on mechanical ventilation, or had SIRS, or were admitted because of trauma or burn were randomized to one of the following treatments: algorithm A -- continuous insulin infusion with adjustments guided by a handheld device or desktop software targeting glucose levels between 100 and 130 mg/dl; algorithm B -- continuous insulin aiming at glucose levels between 80 and 110 mg/dl; algorithm C -- conventional treatment of intermittent subcutaneous administration of insulin if blood glucose levels exceeded 150 mg/dl. Efficacy was measured by the mean of patients\' median blood glucose and safety was measured by the incidence of hypoglycemia (≤40 mg/dl).

Results
=======

One hundred and nine patients were included. The APACHE II score was similar in the groups (20.5 ± 7.9). The efficacy and safety of the algorithms to attain glucose control are presented in Table [1](#T1){ref-type="table"}.

                           Algorithm A (*n*= 36)   Algorithm B (*n*= 36)   Algorithm C (*n*= 37)   *P*all groups   *P*A vs B
  ------------------------ ----------------------- ----------------------- ----------------------- --------------- -----------
  Glucose median (mg/dl)   124.8                   128.5                   161.3                   \<0.001         0.45
  Hypoglycemia (*n*(%))    8 (22.2)                17 (47.2)               0 (0.0)                 \<0.001         0.03
  MICU death (*n*(%))      18 (51.4)               19 (54.3)               15 (40.5)               0.47            0.81

Conclusion
==========

A computer-guided insulin infusion protocol causes less episodes of hypoglycemia than, and is as efficacious as, the standard strict glycemic control protocol for controlling glucose at normal nonfasting levels (80--140 mg/dl) in MICU patients.
